Literature DB >> 16736288

Compliance and Satisfaction with Long-Term Surveillance in Finnish HNPCC Families.

Kirsi Pylvänäinen1, Matti Kairaluoma, Jukka-Pekka Mecklin.   

Abstract

OBJECTIVE: Nation-wide preventative colonoscopic surveillance for mutation carriers in HNPCC families has been organized since the early 1980 by the Finnish HNPCC registry. After characterization of MMR genes, a predisposing mutation has been verified in 111 HNPCC families and over 1500 family members at risk have been tested. The aim of this study was to evaluate the compliance and satisfaction of mutation carriers during life-long colonoscopic surveillance.
MATERIALS AND METHODS: Hospital records of long-term surveillance were obtained for all mutation carriers (n=664). A questionnaire assessing overall experience, willingness to continue the surveillance, painfulness (a three-rank scale), possible interruption of endoscopy and the need for pain relief medication during colonoscopy, was sent to all living mutation carriers (n=587). The questionnaire was returned by 441 persons (75%) of whom 415 persons under colonoscopic surveillance were included in the study and 26 young mutation carriers excluded as they were still pending their first endoscopy.
RESULTS: Out of 664 mutation carriers, surveillance had been interrupted in 8 cases (1.2%). Colonoscopies were described as painful by 151 (36%), uncomfortable by 161 (39%) and easy by 103 (25%) patients. Endoscopy was more often rated as painful by females (1.36, SD 0.71) than by males (0.86, SD 0.75), P<0.001. Medication for pain during colonoscopies was administered more often to females (32%) than males (15%), P<0.001. Colonoscopy had to be discontinued because of pain at least once in 10% of the patients.
CONCLUSION: Patient compliance under life-long surveillance was excellent, but painfulness, especially in females, must be seen as a risk for compliance and the quality of endoscopies.

Entities:  

Mesh:

Year:  2006        PMID: 16736288     DOI: 10.1007/s10689-005-5442-3

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  20 in total

1.  Predictive genetic testing for hereditary non-polyposis colorectal cancer: uptake and long-term satisfaction.

Authors:  K Aktan-Collan; J P Mecklin; H Järvinen; M Nyström-Lahti; P Peltomäki; I Söderling; A Uutela; A de la Chapelle; H Kääriäinen
Journal:  Int J Cancer       Date:  2000-01-20       Impact factor: 7.396

2.  Psychological consequences of predictive genetic testing for hereditary non-polyposis colorectal cancer (HNPCC): a prospective follow-up study.

Authors:  K Aktan-Collan; A Haukkala; J P Mecklin; A Uutela; H Kääriäinen
Journal:  Int J Cancer       Date:  2001-08-15       Impact factor: 7.396

Review 3.  Recommendations for follow-up care of individuals with an inherited predisposition to cancer. I. Hereditary nonpolyposis colon cancer. Cancer Genetics Studies Consortium.

Authors:  W Burke; G Petersen; P Lynch; J Botkin; M Daly; J Garber; M J Kahn; A McTiernan; K Offit; E Thomson; C Varricchio
Journal:  JAMA       Date:  1997-03-19       Impact factor: 56.272

4.  Screening behavior of individuals at high risk for colorectal cancer.

Authors:  Eveline M A Bleiker; Fred H Menko; Babs G Taal; Irma Kluijt; Lidwina D V Wever; Miranda A Gerritsma; Hans F A Vasen; Neil K Aaronson
Journal:  Gastroenterology       Date:  2005-02       Impact factor: 22.682

5.  New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC.

Authors:  H F Vasen; P Watson; J P Mecklin; H T Lynch
Journal:  Gastroenterology       Date:  1999-06       Impact factor: 22.682

6.  Patient pain during colonoscopy: an analysis using real-time magnetic endoscope imaging.

Authors:  S G Shah; J C Brooker; C Thapar; C B Williams; B P Saunders
Journal:  Endoscopy       Date:  2002-06       Impact factor: 10.093

Review 7.  Genetics, natural history, tumor spectrum, and pathology of hereditary nonpolyposis colorectal cancer: an updated review.

Authors:  H T Lynch; T C Smyrk; P Watson; S J Lanspa; J F Lynch; P M Lynch; R J Cavalieri; C R Boland
Journal:  Gastroenterology       Date:  1993-05       Impact factor: 22.682

8.  High compliance rates observed for follow up colonoscopy post polypectomy are achievable outside of clinical trials: efficacy of polypectomy is not reduced by low compliance for follow up.

Authors:  P Colquhoun; H-C Chen; Jong Ik Kim; J Efron; E G Weiss; J J Nogueras; A M Vernava; S D Wexner
Journal:  Colorectal Dis       Date:  2004-05       Impact factor: 3.788

9.  Prevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup.

Authors:  S J Winawer; A G Zauber; M N Ho; M J O'Brien; L S Gottlieb; S S Sternberg; J D Waye; M Schapiro; J H Bond; J F Panish
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245

10.  Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis.

Authors:  H F Vasen; J T Wijnen; F H Menko; J H Kleibeuker; B G Taal; G Griffioen; F M Nagengast; E H Meijers-Heijboer; L Bertario; L Varesco; M L Bisgaard; J Mohr; R Fodde; P M Khan
Journal:  Gastroenterology       Date:  1996-04       Impact factor: 22.682

View more
  18 in total

1.  Screening adherence and cancer risk perceptions in colorectal cancer survivors with Lynch-like syndrome.

Authors:  L H Katz; A M Burton-Chase; S Advani; B Fellman; K M Polivka; Y Yuan; P M Lynch; S K Peterson
Journal:  Clin Genet       Date:  2015-09-14       Impact factor: 4.438

2.  Identification and surveillance of 19 Lynch syndrome families in southern Italy: report of six novel germline mutations and a common founder mutation.

Authors:  Patrizia Lastella; Margherita Patruno; Giovanna Forte; Alba Montanaro; Carmela Di Gregorio; Carlo Sabbà; Patrizia Suppressa; Adalgisa Piepoli; Anna Panza; Angelo Andriulli; Nicoletta Resta; Alessandro Stella
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

3.  Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome.

Authors:  Elena M Stoffel; Rowena C Mercado; Wendy Kohlmann; Beth Ford; Shilpa Grover; Peggy Conrad; Amie Blanco; Kristen M Shannon; Mark Powell; Daniel C Chung; Jonathan Terdiman; Stephen B Gruber; Sapna Syngal
Journal:  Am J Gastroenterol       Date:  2010-03-30       Impact factor: 10.864

Review 4.  Performance measures for lower gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy (ESGE) quality improvement initiative.

Authors:  Michal F Kaminski; Siwan Thomas-Gibson; Marek Bugajski; Michael Bretthauer; Colin J Rees; Evelien Dekker; Geir Hoff; Rodrigo Jover; Stepan Suchanek; Monika Ferlitsch; John Anderson; Thomas Roesch; Rolf Hultcranz; Istvan Racz; Ernst J Kuipers; Kjetil Garborg; James E East; Maciej Rupinski; Birgitte Seip; Cathy Bennett; Carlo Senore; Silvia Minozzi; Raf Bisschops; Dirk Domagk; Roland Valori; Cristiano Spada; Cesare Hassan; Mario Dinis-Ribeiro; Matthew D Rutter
Journal:  United European Gastroenterol J       Date:  2017-03-16       Impact factor: 4.623

5.  A mobile colonoscopic unit for lynch syndrome: trends in surveillance uptake and patient experiences of screening in a developing country.

Authors:  Zandrè Bruwer; Merle Futter; Raj Ramesar
Journal:  J Genet Couns       Date:  2013-01-09       Impact factor: 2.537

6.  Changes in screening behaviors and attitudes toward screening from pre-test genetic counseling to post-disclosure in Lynch syndrome families.

Authors:  A M Burton-Chase; S R Hovick; S K Peterson; S K Marani; S W Vernon; C I Amos; M L Frazier; P M Lynch; E R Gritz
Journal:  Clin Genet       Date:  2013-03       Impact factor: 4.438

7.  Causes of death of mutation carriers in Finnish Lynch syndrome families.

Authors:  Kirsi Pylvänäinen; Tuula Lehtinen; Ilmo Kellokumpu; Heikki Järvinen; Jukka-Pekka Mecklin
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

8.  Hereditary colorectal cancer registries in Canada: report from the Colorectal Cancer Association of Canada consensus meeting; Montreal, Quebec; October 28, 2011.

Authors:  H Rothenmund; H Singh; B Candas; B N Chodirker; K Serfas; M Aronson; S Holter; A Volenik; J Green; E Dicks; M O Woods; D Gilchrist; R Gryfe; Z Cohen; W D Foulkes
Journal:  Curr Oncol       Date:  2013-10       Impact factor: 3.677

9.  Sharing genetic risk with next generation: mutation-positive parents' communication with their offspring in Lynch Syndrome.

Authors:  Katja I Aktan-Collan; Helena A Kääriäinen; Eeva M Kolttola; Kirsi Pylvänäinen; Heikki J Järvinen; Ari H Haukkala; Jukka-Pekka Mecklin
Journal:  Fam Cancer       Date:  2011-03       Impact factor: 2.375

10.  Patient compliance based on genetic medicine: a literature review.

Authors:  Kai Insa Schneider; Jörg Schmidtke
Journal:  J Community Genet       Date:  2013-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.